Some doctors may be unaware of the regional/distant metastasis-cost-free survival gain described in a very subsequent publication, where the regional and distant metastatic failure charge was reduced by virtually 50 % while in the focal boost arm [2]. Added ongoing trials could also corroborate the FLAME benefits, encouraging adoption. The https://biib02133209.tkzblog.com/28930350/not-known-facts-about-betaine